201 related articles for article (PubMed ID: 23922895)
1. Structural basis for the regulation of maternal embryonic leucine zipper kinase.
Cao LS; Wang J; Chen Y; Deng H; Wang ZX; Wu JW
PLoS One; 2013; 8(7):e70031. PubMed ID: 23922895
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation.
Jaleel M; Villa F; Deak M; Toth R; Prescott AR; Van Aalten DM; Alessi DR
Biochem J; 2006 Mar; 394(Pt 3):545-55. PubMed ID: 16396636
[TBL] [Abstract][Full Text] [Related]
3. The structures of the kinase domain and UBA domain of MPK38 suggest the activation mechanism for kinase activity.
Cho YS; Yoo J; Park S; Cho HS
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):514-21. PubMed ID: 24531485
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the kinase and UBA domains of SNRK reveals a distinct UBA binding mode in the AMPK family.
Wang YL; Wang J; Chen X; Wang ZX; Wu JW
Biochem Biophys Res Commun; 2018 Jan; 495(1):1-6. PubMed ID: 29061304
[TBL] [Abstract][Full Text] [Related]
5. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity.
Tang BF; Yan RC; Wang SW; Zeng ZC; Du SS
Cancer Lett; 2023 Apr; 560():216126. PubMed ID: 36933780
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C).
Rembacz KP; Zrubek KM; Golik P; Michalik K; Bogusz J; Wladyka B; Romanowska M; Dubin G
Arch Biochem Biophys; 2019 Aug; 671():1-7. PubMed ID: 31108049
[TBL] [Abstract][Full Text] [Related]
7. Structural insight into maternal embryonic leucine zipper kinase (MELK) conformation and inhibition toward structure-based drug design.
Canevari G; Re Depaolini S; Cucchi U; Bertrand JA; Casale E; Perrera C; Forte B; Carpinelli P; Felder ER
Biochemistry; 2013 Sep; 52(37):6380-7. PubMed ID: 23914841
[TBL] [Abstract][Full Text] [Related]
8. Conformational instability of the MARK3 UBA domain compromises ubiquitin recognition and promotes interaction with the adjacent kinase domain.
Murphy JM; Korzhnev DM; Ceccarelli DF; Briant DJ; Zarrine-Afsar A; Sicheri F; Kay LE; Pawson T
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14336-41. PubMed ID: 17726107
[TBL] [Abstract][Full Text] [Related]
9. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.
Perry NA; Fialkowski KP; Kaoud TS; Kaya AI; Chen AL; Taliaferro JM; Gurevich VV; Dalby KN; Iverson TM
Cell Signal; 2019 Nov; 63():109366. PubMed ID: 31352007
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity and activity regulation of protein kinase MELK.
Beullens M; Vancauwenbergh S; Morrice N; Derua R; Ceulemans H; Waelkens E; Bollen M
J Biol Chem; 2005 Dec; 280(48):40003-11. PubMed ID: 16216881
[TBL] [Abstract][Full Text] [Related]
11. Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1.
Panneerselvam S; Marx A; Mandelkow EM; Mandelkow E
Structure; 2006 Feb; 14(2):173-83. PubMed ID: 16472737
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-associated domain of AMPK-related protein kinases allows LKB1-induced phosphorylation and activation.
Rider MH
Biochem J; 2006 Mar; 394(Pt 3):e7-9. PubMed ID: 16492140
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor.
Cho YS; Kang Y; Kim K; Cha YJ; Cho HS
Biochem Biophys Res Commun; 2014 Apr; 447(1):7-11. PubMed ID: 24657156
[TBL] [Abstract][Full Text] [Related]
14. Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2.
Marx A; Nugoor C; Müller J; Panneerselvam S; Timm T; Bilang M; Mylonas E; Svergun DI; Mandelkow EM; Mandelkow E
J Biol Chem; 2006 Sep; 281(37):27586-99. PubMed ID: 16803889
[TBL] [Abstract][Full Text] [Related]
15. MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies.
Thangaraj K; Ponnusamy L; Natarajan SR; Manoharan R
Drug Discov Today; 2020 Dec; 25(12):2161-2173. PubMed ID: 33010478
[TBL] [Abstract][Full Text] [Related]
16. Activity of the human centrosomal kinase, Nek2, depends on an unusual leucine zipper dimerization motif.
Fry AM; Arnaud L; Nigg EA
J Biol Chem; 1999 Jun; 274(23):16304-10. PubMed ID: 10347187
[TBL] [Abstract][Full Text] [Related]
17. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
[TBL] [Abstract][Full Text] [Related]
18. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.
Pirruccello M; Sondermann H; Pelton JG; Pellicena P; Hoelz A; Chernoff J; Wemmer DE; Kuriyan J
J Mol Biol; 2006 Aug; 361(2):312-26. PubMed ID: 16837009
[TBL] [Abstract][Full Text] [Related]
19. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
Mahasenan KV; Li C
J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
